National Health Investors, Inc. (NHI)

NYSE: NHI · USD

$65.5

-0.93 (-1.4%)· Recorded snapshot

Market cap	3.2B
Revenue (ttm)	435.8M
Net income (ttm)	166.5M
EPS (ttm)	$3.46
Shares out	49.1M
P/E (trailing)	18.9x
P/E (forward)	17.0x
Dividend	$3.76 (5.74%)
Volume	160,491
Beta	0.52

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 435.8M
Net income (ttm): 166.5M
EPS (ttm): $3.46
P/E (trailing): 18.9x
P/E (forward): 17.0x
Market cap: 3.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AMT	American Tower Corporation	85.1B	25.8x	7.5x	7.8%	+4.0%	+0.7%	تخفيض
ARE	Alexandria Real Estate Equities Inc.	6.9B	—	2.4x	0.9%	+6.6%	-45.8%	احتفاظ
CCI	Crown Castle Inc.	37.4B	46.3x	9.1x	5.1%	-7.9%	-6.2%	بيع

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17

P25 n/aP50 n/aP75 n/a

Trailing P/E18.9

P25 n/aP50 n/aP75 n/a

ROE10.7

P25 n/aP50 n/aP75 n/a

ROIC7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NHI indicators

Market & fundamental data

Available fields

264

Groups with data

Currency

USD

Showing 264 of 264 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000877860
Company name	National Health Investors, Inc.
Country	United States
Country code	US
CUSIP number	63633D104
Earnings date	2026-11-09
Earnings time	amc
Employees	32
Employees change	2
Employees growth	6.67%
Enterprise value	$4.5B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1991
In index	RUSSELL2000
Industry	REIT - Healthcare Facilities
IPO date	1991-10-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US63633D1046
Last 10-K release date	2026-02-26
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$65.53
Price currency	USD
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-28
Symbol	NHI
U.S. state	Tennessee
Website	https://www.nhireit.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	19.48x
Average P/E ratio (10Y)	22.35x
Average P/E ratio (3Y)	23.59x
Average P/E ratio (5Y)	25.57x
Earnings yield	5.29%
EV/Earnings	26.78x
EV/EBIT	22.46x
EV/EBITDA	15.4x
EV/Sales	10.23x
FCF / EV yield	-3.38%
FCF yield	-4.69%
Forward EV/Sales	9.61x
Forward P/E	17x
Forward P/S	6.92x
Graham number	49.93938
Graham upside	-23.64%
Industry forward P/E	66.06x
Industry P/E	78.26x
Lynch fair value	$17.32
Lynch upside	-73.51%
P/(OCF - SBC) ratio	13.26x
P/B ratio	2.08x
P/E ratio	18.92x
P/FFO ratio	13.81x
P/OCF ratio	12.92x
P/S ratio	7.37x
PEG ratio	5.23x
Price / tangible book value	2.04x
Price/EBITDA ratio	11.09x
Sector forward P/E	29.99x
Sector P/E	40.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	45.57%
EBITDA margin	66.47%
Effective tax rate	0.44%
Gross margin	73.93%
Operating margin	45.57%
Pretax margin	38.12%
Profit margin	38.28%
Profit per employee	$5.2M
Profitable quarters	94
Profitable years	24
Revenue per employee	$13.6M
ROA	4.39%
ROA (5Y)	4.17%
ROCE	6.91%
ROE	10.72%
ROE (5Y)	8.48%
ROIC	6.97%
ROIC (5Y)	6.88%
SBC / revenue	1.5%
Tax / revenue	0.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	10.43%
EPS growth (Q)	45.24%
EPS growth (QoQ)	39.93%
EPS growth 10Y	-2.22%
EPS growth 3Y	11.05%
EPS growth 5Y	0.32%
EPS growth quarters	2
EPS growth years	0
Net income growth	16.7%
Net income growth (Q)	50.52%
Net income growth (QoQ)	38.86%
Net income growth 3Y	14.62%
Net income growth 5Y	1.54%
Net income growth quarters	2
Net income growth years	3
OCF growth	17.03%
OCF growth (Q)	8.62%
OCF growth (QoQ)	21.58%
OCF growth 10Y	4.02%
OCF growth 3Y	13.2%
OCF growth 5Y	2.13%
Revenue growth	24.99%
Revenue growth (Q)	33.82%
Revenue growth (QoQ)	5.38%
Revenue growth 10Y	6.35%
Revenue growth 3Y	12.36%
Revenue growth 5Y	6.56%
Revenue growth quarters	9
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-399.3M
Depreciation and amortization	$91.1M
EBIT	$198.6M
EBITDA	$289.7M
EPS	$3.46
FCF per share	$-3.07
Financing cash flow	$75.1M
Free cash flow	$-150.6M
Free cash flow minus SBC	$-157.1M
Funds from operations (FFO)	$228M
Gross profit	$322.2M
Income taxes	$732,000
Investing cash flow	$-292.7M
Net cash flow	$31.1M
Net income	$166.5M
Operating cash flow minus SBC	$242.1M
Operating income	$198.6M
Revenue	$435.8M
Stock-based compensation	$6.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$31.99
Debt / EBITDA	4.41
Debt / equity	0.8
Interest coverage	3.37
Net cash (debt)	$-1.2B
Net cash / market cap	-38.85%
Net debt / EBITDA	4.31
Net debt / equity	0.79
Piotroski F-Score	6
Property, plant and equipment	$2.6B
Shareholders' equity	$1.6B
Tangible book value	$1.6B
Tangible book value per share	$31.99
Total assets	$3B
Total cash	$30.4M
Total debt	$1.3B
Total liabilities	$1.4B
WACC	6.39%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.15
Current ratio	1.82
Net working capital	$44.8M
Quick ratio	1.19
Working capital	$75.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.73%
Dividend growth	2.21%
Dividend growth (10Y)	0.41%
Dividend growth (3Y)	0.92%
Dividend growth (5Y)	-1.57%
Dividend growth years	1
Dividend payment date	2026-11-06
Dividend payment years	36
Dividend payout frequency	Quarterly
Dividend per share	$3.76
Dividend yield	5.74%
Ex-dividend date	2026-09-30
Last dividend	$0.94
Payout ratio	108.53%
Shareholder yield	0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-12.48%
10Y return CAGR	4.5%
10Y total return	55.33%
150-day SMA	$73.92
15Y price change	42.83%
15Y return CAGR	8.28%
15Y total return	229.89%
1D price change	-1.4%
1M price change	-2.72%
1M total return	-1.33%
1W price change	-1.88%
1W total return	-1.88%
1Y price change	-14.12%
1Y return CAGR	-9.78%
1Y total return	-9.78%
20-day SMA	$65.61
200-day SMA	$76.50
20Y price change	104.78%
20Y return CAGR	10.12%
20Y total return	587.78%
3M price change	-17.89%
3M total return	-16.71%
3Y price change	31.78%
3Y return CAGR	15.4%
3Y total return	53.69%
50-day SMA	$68.37
50-day SMA vs 200-day SMA	50under200
52-week high	$91.38
52-week high date	2026-02-17
52-week low	$63.51
52-week low date	2026-10-08
5Y price change	14.01%
5Y return CAGR	8.69%
5Y total return	51.64%
6M price change	-15.62%
6M total return	-13.39%
All-time high	$91.38
All-time high date	2026-02-17
All-time low	$4.88
All-time low date	2000-08-17
Average true range (ATR)	$1.44
Average volume	291.8K
Beta (1Y)	-0.36
Beta (2Y)	0.15
Beta (5Y)	0.52
Change from 52-week high	-28.29%
Change from 52-week low	3.18%
Change from all-time high	-28.76%
Change from all-time low	1,235.38%
Change from open	0.31%
Day's gap	-1.7%
Dollar volume	$10.5M
High price	$65.53
Low price	$65.10
Monthly RSI	41.6
Open price	$65.33
Position in 52-week range	100%
Premarket change	-0.98%
Premarket close	$66.46
Premarket price	$65.81
Previous close	$66.46
Price vs 150-day SMA	-11.93%
Price vs 20-day SMA	-0.78%
Price vs 200-day SMA	-14.9%
Price vs 50-day SMA	-4.78%
Relative volume	0.55
RSI	42.81
Sharpe ratio	-0.48
Sharpe ratio (3Y)	0.61
Sharpe ratio (5Y)	0.3
Sortino ratio	-0.42
Sortino ratio (3Y)	1.14
Sortino ratio (5Y)	0.67
Volume	160.5K
Weekly RSI	34.57
YTD price change	-14.76%
YTD total return	-11.51%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47.9M
Float percentage	97.61%
Shares change (QoQ)	-0.1%
Shares change (YoY)	5.73%
Shares held by insiders	2.39%
Shares held by institutions	78.17%
Shares outstanding	49.1M
Short % of float	4.99%
Short % of shares	4.87%
Short ratio	6.1 days

Deeper analysis on NHI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NHI report

Is a complete NHI research report available?

No complete published report is available for National Health Investors, Inc. (NHI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

National Health Investors, Inc. (NHI)

Price

Financial snapshot

Fair-value bridge

Latest news · NHI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NHI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NHI

Frequently asked questions